Explore more publications!

Health Wire East Timor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire East Timor.

February 2026

March 2026

April 2026

Press releases published on March 28, 2026

Gelatin Trick 2026 Warning: Does the Viral Gelatin Trick Recipe Actually Work? — Pink Gelatin Trick, Ice Gelatin Trick, Bariatric Jello, and Why Consumers Are Choosing Gelatine Sculpt Instead (New Investigation)

Mar. 28, 2026

Gelatin Trick 2026 Warning: Does the Viral Gelatin Trick Recipe Actually Work? — Pink Gelatin Trick, Ice Gelatin Trick, Bariatric Jello, and Why Consumers Are Choosing Gelatine Sculpt Instead (New Investigation)

GlobeNewswire

Steel Power Male Enhancement Claims Evaluated: Complete SteelPower Performance Report for Men

Mar. 28, 2026

Steel Power Male Enhancement Claims Evaluated: Complete SteelPower Performance Report for Men

GlobeNewswire

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

Mar. 28, 2026

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

GlobeNewswire

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity

Mar. 28, 2026

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity

GlobeNewswire

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

Mar. 28, 2026

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

GlobeNewswire

Gelatide Drops Under Investigation: Full Gelatide-1 Consumer Report Reveals Shocking Hidden Risks & Fake Gelatin Trick Recipe

Mar. 28, 2026

Gelatide Drops Under Investigation: Full Gelatide-1 Consumer Report Reveals Shocking Hidden Risks & Fake Gelatin Trick Recipe

GlobeNewswire

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

Mar. 28, 2026

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

GlobeNewswire

SonusZen Claims Evaluated: Testing the Legitimacy of Sonus Zen Formulation for Hearing Support

Mar. 28, 2026

SonusZen Claims Evaluated: Testing the Legitimacy of Sonus Zen Formulation for Hearing Support

GlobeNewswire

Communiqué de presse : AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute

Mar. 28, 2026

Communiqué de presse : AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute

GlobeNewswire

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

Mar. 28, 2026

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

GlobeNewswire

Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

Mar. 28, 2026

Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

GlobeNewswire

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

Mar. 28, 2026

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

GlobeNewswire

TheraWolf PainBalm and NeuroBalm Claims Evaluated: What Buyers Are Overlooking About Topical Relief Formulas, Ingredients, and Pricing in 2026

Mar. 28, 2026

TheraWolf PainBalm and NeuroBalm Claims Evaluated: What Buyers Are Overlooking About Topical Relief Formulas, Ingredients, and Pricing in 2026

GlobeNewswire